Coming off of what was an incredible week for my brokerage account, I’m excited for a brand new week of TrackStar opportunities, financial professional analysis, and trading alongside Wall Street’s biggest players…
Ticker Code | Ticker Name | Ticker Industry | Price Change | Average Volume (50)* |
AYTU | Aytu Bioscience Inc | Biotechnology | 3.85% | 19,105,194 |
MVIS | Microvision, Inc. | Scientific & Technical Instruments | 79.76% | 40,179,245 |
MARK | Remark Holdings Inc | Internet Content & Information | 70.00% | 43,489,485 |
VTIQ | VECTOIQ ACQUISI/SH | Conglomerates | 52.96% | 4,350,906 |
TTNP | Titan Pharmaceuticals, Inc. common stock | Biotechnology | 17.86% | 10,301,521 |
NVAX | Novavax, Inc. | Biotechnology | 68.87% | 10,463,397 |
NIO | Nio Inc – ADR | Auto Manufacturers | 17.51% | 30,178,985 |
INO | Inovio Pharmaceuticals Inc | Biotechnology | 44.60% | 37,230,152 |
ZEST | Ecoark Holdings Inc | Plastics products, misc | 49.57% | 485,415 |
CODX | Co-Diagnostics Inc | Diagnostics & Research | 55.36% | 10,896,202 |
GNUS | Genius Brands International Inc | Entertainment | 81.33% | 20,853,457 |
TSLA | Tesla Inc | Auto Manufacturers | 34.43% | 17,719,492 |
EMAN | eMagin Corporation | Semiconductor Equipment & Materials | 66.13% | 3,181,676 |
WTRH | Waitr Holdings Inc | Conglomerates | 56.07% | 8,945,294 |
UNFI | United Natural Foods Inc | Food Distribution | 49.89% | 2,569,458 |
ACB | Aurora Cannabis Inc | Drug Manufacturers – Specialty & Generic | 2.95% | 6,247,497 |
AAPL | Apple Inc. | Consumer Electronics | 17.36% | 38,930,422 |
JCP | J C Penney Company Inc | Department Stores | -50.00% | 37,921,572 |
IBIO | Ibio Inc | Biotechnology | 28.38% | 12,322,669 |
RTTR | Ritter Pharmaceuticals Inc | Biotechnology | 57.14% | 20,301,190 |
We’re living in a world in which almost any improvement to society, including improvements to physical and mental health, is desired and considered an urgent matter.
Citizens are awaiting items such as a vaccine, new legal announcements regarding current stay-at-home mandates, and even new seasons of their favorite shows to be streamed on Netflix.
While it may go overlooked to some, there is a novel instrument that is now essential to identifying coronavirus hotspots – areas which require urgent attention in order to prevent an increase in the spread of cases.
Tracking devices. And guess which company has been the world’s #1 provider of tracking devices, technology improvements, and apps that immediately notify government officials of new coronavirus cases?
Apple (NYSE: AAPL). About twenty three hours ago, Apple was rumored to be the new leading provider of bluetooth-friendly smartphone tracking apps in the entire continent of Europe. Achieving this new standing would mean big things for Apple, and likely increase the company’s revenue and demand in a significant manner.
If the rumored ascension transpires, I’d expect a bullish pop in Apple’s stock – even if markets were red on a given trading day.
Apple’s chart is intriguing this morning (and through the rest of this week) as Apple has range to $319.68/share from its premarket price of about $310/share.
Should markets open above $319.68, and Apple could trade as high as $330/share as traders observe a short-term breakout taking place, and become interested in trading a piece or two of it.
While Apple is indeed on my radar, it frequently offers highly liquid trading opportunities in both green and red markets, and does not appear to be buckling from the multi-faceted challenges brought on by the COVID-19 crisis.
Therefore, I expect Apple to remain on my TrackStar trading watchlist through the course of this week.
On a final note, Apple often trades via dark pool investing – stay tuned for that new video lesson.
Yours for TrackStar trading,
Davis Martin
America’s #1 Premarket and Day Trader
Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.